Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.36 |
| ▸ | PRKCG | P05129 | 2/20 | 0.36 |
| ▸ | PRKCB | P05771 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.36 |
| ▸ | PRKCH | P24723 | 2/20 | 0.36 |
| ▸ | PRKCI | P41743 | 2/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.36 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Domiodol SCHEMBL19352 | 0.83 | — | — | |
| Domiodol SCHEMBL11633809 | 0.83 | — | — | |
| SCHEMBL252279 | 0.80 | — | — | |
| SCHEMBL11631029 | 0.79 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL4876623 | 0.79 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL11630861 | 0.79 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10817323 | 0.79 | ALDH1A1 (0.37) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL4870948 | 0.78 | PRKD3 (0.53) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL6113854 | 0.76 | PRKD3 (0.59) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10811970 | 0.76 | PRKD3 (0.35) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137888-A1 | COMPOSITION FOR UPPER RESPIRATORY TRACT ADMINISTRATION AND METHOD THEREOF | ORIGINAL BIOMEDICALS CO., LTD. (TW) | 2023-05-04 | — | — | US | claimed |
| EP-4173618-A1 | COMPOSITION FOR UPPER RESPIRATORY TRACT ADMINISTRATION COMPRISING A METAL CHELATOR AND A CYANIDE ANTIDOTE AND METHOD THEREOF | Original Biomedicals Co., Ltd. (TW) | 2023-05-03 | — | — | EP | claimed |
| US-20200179409-A1 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING THE SAME | CMPD LICENSING, LLC (US) | 2020-06-11 | — | — | US | claimed |
| US-20190247030-A1 | System and Method for Collecting, Enriching and Isolating Trophoblast Cells From Endocervical Canal | TROPHODIAGNOSTICS, LLC (US) | 2019-08-15 | — | — | US | claimed |
| EP-3513787-A1 | USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION | Invion, Inc (AU) | 2019-07-24 | — | — | EP | claimed |
| WO-2019021065-A2 | NEW SYSTEM AND METHOD FOR COLLECTING, ENRICHING, AND ISOLATING TROPHOBLAST CELLS FROM ENDOCERVICAL CANAL | TROPHODIAGNOSTICS, LLC (US) | 2019-01-31 | — | — | WO | claimed |
| US-8486375-B2 | Foamable compositions | FOAMIX LTD. (IL) | 2013-07-16 | — | — | US | claimed |
| EP-2608847-A1 | THEOBROMINE IN COMBINATION WITH AN EXPECTORANT OR A MUCOLYTIC FOR USE IN THERAPY | Biocopea Limited (GB) | 2013-07-03 | — | — | EP | claimed |
| US-20130004480-A1 | CD20 Binding Molecules for the Treatment of Copd | GENMAB A/S (DK) | 2013-01-03 | — | — | US | claimed |
| US-20120195836-A1 | Foamable Iodine Compositions | Foamix | 2012-08-02 | — | — | US | claimed |
| WO-2001070242-A2 | COMPOSITIONS CONTAINING MOLECULAR IODINE | BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2001-09-27 | — | — | WO | claimed |
| WO-2001012584-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2001-02-22 | — | — | WO | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| EP-0768819-A4 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS | INNOVATIVE TECH CENTER (US) | 1999-10-13 | — | — | EP | claimed |
| EP-0768819-A1 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS | THE CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1997-04-23 | — | — | EP | claimed |
| WO-1996004787-A1 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS | THE CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-02-22 | — | — | WO | claimed |
| US-5492689-A | Combined virustatic antimediator (COVAM) treatment of common colds | THE CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-02-20 | — | — | US | claimed |
| WO-1994018970-A1 | COLD/SINUS PREPARATION CONSISTING OF PHENINDAMINE TARTARATE WITH OR WITHOUT THERAPEUTIC AGENTS | WARNER-LAMBERT COMPANY (US) | 1994-09-01 | — | — | WO | claimed |
| EP-0530311-A1 | THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS | Norwich-Eaton Pharmaceuticals, Inc. (US) | 1993-03-10 | — | — | EP | claimed |
| WO-1991017746-A1 | THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1991-11-28 | — | — | WO | claimed |